Crescent Biopharma Inc At Strategic Partnership & Pipeline Update Transcript
Welcome to the Crescent BioPharma conference call. All participants will be in a listen-only mode. Later, we will conduct a question-and-answer session. I would now like to turn the conference over to Amy Riley. Amy, you may begin.
Thank you for joining us for our call today to discuss the partnership, Creston announced with Kalo Biotech, as well as a comprehensive review of our pipeline.
Before we get started, I'd like to remind everyone that we will be making forward-looking statements today that are subject to the safe harbor protections provided under the Private Securities Litigation Reform Act of 1,995.
Actual results may differ materially from these forward-looking statements as a result of various important factors, including those discussed in the risk factors section of our most recent form, 10Q.
These statements represent Crescent view as of today's date, and we disclaim any obligation to update these statements except as required by law.
Joining
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
